<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1471-2180-1-12.anc" start="28522" end="28526" sStart="28387" offset="135" sid="r10.wait.v.0829" wn="1" wnkey="wait%2:42:00::" text="Understanding the mechanism of the template/substrate commitment of the hepadnaviral reverse transcriptase may need to wait until a three-dimensional structure of the polymerase bound to a nucleic acid primer-template is obtained." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2180-1-12.anc" start="30529" end="30533" sStart="null" offset="61" sid="r7.1.use.v.0383" wn="1" wnkey="use%2:34:01::" text="The D2526+/D2507- and D2453+/D2543M-Sal pairs were used with DRF+ RNA, and the D1433+/ D1452- pair was used with DXB+ RNA." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-1-12.anc" start="1241" end="1252" sStart="null" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" text="During synthesis of the minus-strand DNA the pregenomic RNA is degraded by the ribonuclease H (RNAseH) activity of P. However, the RNAseH activity does not digest the extreme 5' end of the template RNA, and this ? 18 nucleotide capped RNA fragment is then &lt;b&gt;transferred&lt;/b&gt; to direct repeat 2 (DR2), where it acts as a primer for synthesis of plus-strand DNA [ 11, 12]." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-1-12.anc" start="693" end="704" sStart="null" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" text="DNA synthesis arrests after 3-4 nucleotides, and then the protein-linked nascent minus-strand DNA is &lt;b&gt;transferred&lt;/b&gt; to the copy of direct repeat 1 (DR1) within the 3' terminal duplication." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2180-1-12.anc" start="15372" end="15380" sStart="null" offset="5" sid="r8.suggest.v.0504" wn="3" wnkey="suggest%2:32:02::" text="This suggests that (i) there is no obvious nucleotide requirement to activate the RNAseH activity, and (ii) any DNA synthesis that may have occurred on the substrates during the reaction (either primed by the oligonucleotide or produced by the trans reaction) was insufficient to induce detectable RNAseH activity." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-1-12.anc" start="19267" end="19274" sStart="null" offset="0" sid="null" wn="2" wnkey="success%1:04:00::" text="Two different sources of recombinant, enzymatically active DHBV P were also employed in the RNAseH assays without &lt;b&gt;success&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-1-12.anc" start="17638" end="17645" sStart="null" offset="0" sid="null" wn="1" wnkey="success%1:11:00::" text="To determine if the lack of &lt;b&gt;success&lt;/b&gt; was specific to the DRF+ RNA, a second RNA, DXB+ (DHBV nt 1358-1504 positive polarity), annealed to the complementary oligonucleotide D1452- was employed in RNAseH assays." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-1-12.anc" start="19267" end="19274" sStart="null" offset="0" sid="null" wn="2" wnkey="success%1:04:00::" text="Two different sources of recombinant, enzymatically active DHBV P were also employed in the RNAseH assays without &lt;b&gt;success&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-1-12.anc" start="17638" end="17645" sStart="null" offset="0" sid="null" wn="2" wnkey="success%1:04:00::" text="To determine if the lack of &lt;b&gt;success&lt;/b&gt; was specific to the DRF+ RNA, a second RNA, DXB+ (DHBV nt 1358-1504 positive polarity), annealed to the complementary oligonucleotide D1452- was employed in RNAseH assays." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-1-12.anc" start="19267" end="19274" sStart="null" offset="0" sid="null" wn="1" wnkey="success%1:11:00::" text="Two different sources of recombinant, enzymatically active DHBV P were also employed in the RNAseH assays without &lt;b&gt;success&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-1-12.anc" start="17638" end="17645" sStart="null" offset="0" sid="null" wn="1" wnkey="success%1:11:00::" text="To determine if the lack of &lt;b&gt;success&lt;/b&gt; was specific to the DRF+ RNA, a second RNA, DXB+ (DHBV nt 1358-1504 positive polarity), annealed to the complementary oligonucleotide D1452- was employed in RNAseH assays." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2180-1-12.anc" start="7732" end="7737" sStart="null" offset="0" sid="null" wn="4" wnkey="show%2:39:00::" text="The detection limit of this assay was less than 0.00001 U E. coli RNAseH (data not &lt;b&gt;shown&lt;/b&gt;)." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2180-1-12.anc" start="7732" end="7737" sStart="null" offset="0" sid="null" wn="5" wnkey="show%2:36:00::" text="The detection limit of this assay was less than 0.00001 U E. coli RNAseH (data not &lt;b&gt;shown&lt;/b&gt;)." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2180-1-12.anc" start="7732" end="7737" sStart="null" offset="0" sid="null" wn="4" wnkey="show%2:39:00::" text="The detection limit of this assay was less than 0.00001 U E. coli RNAseH (data not &lt;b&gt;shown&lt;/b&gt;)." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2180-1-12.anc" start="7732" end="7737" sStart="null" offset="0" sid="null" wn="1" wnkey="show%2:39:02::" text="The detection limit of this assay was less than 0.00001 U E. coli RNAseH (data not &lt;b&gt;shown&lt;/b&gt;)." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2180-1-12.anc" start="7732" end="7737" sStart="null" offset="0" sid="null" wn="4" wnkey="show%2:39:00::" text="The detection limit of this assay was less than 0.00001 U E. coli RNAseH (data not &lt;b&gt;shown&lt;/b&gt;)." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2180-1-12.anc" start="7732" end="7737" sStart="null" offset="0" sid="null" wn="5" wnkey="show%2:36:00::" text="The detection limit of this assay was less than 0.00001 U E. coli RNAseH (data not &lt;b&gt;shown&lt;/b&gt;)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-1-12.anc" start="2984" end="2990" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" text="(ii) Mutation of the putative RNAseH active site residues in both Hepatitis B Virus (HBV) and duck hepatitis B virus (DHBV) P blocks synthesis of &lt;b&gt;mature&lt;/b&gt; hepadnaviral DNA and results in the expected RNA:DNA heteroduplex [ 19, 21, 22, 23]." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-1-12.anc" start="2984" end="2990" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" text="(ii) Mutation of the putative RNAseH active site residues in both Hepatitis B Virus (HBV) and duck hepatitis B virus (DHBV) P blocks synthesis of &lt;b&gt;mature&lt;/b&gt; hepadnaviral DNA and results in the expected RNA:DNA heteroduplex [ 19, 21, 22, 23]." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2180-1-12.anc" start="24264" end="24268" sStart="null" offset="137" sid="r9.fold.v.0631" wn="2147483645" wnkey="null" text="Therefore, the turnover number for the RNAseH activity needed to reach the detection limit in our assays is about 43,000-fold less than the 40 cycles observed for the polymerase activity under very similar conditions." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2180-1-12.anc" start="17961" end="17970" sStart="null" offset="113" sid="r8.1.different.j.0243" wn="1" wnkey="different%3:00:00::" text="Again, no specific DHBV RNAseH cleavage was observed (data not shown), indicating that using different region of RNA from the DHBV genome did not affect the observation that the DHBV RNAseH could not engage an exogenous substrate." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2180-1-12.anc" start="8769" end="8777" sStart="null" offset="5" sid="r10.control.n.0672" wn="4" wnkey="control%1:09:02::" text="Five controls were performed to ensure that these negative results were not artifacts." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2180-1-12.anc" start="28971" end="28979" sStart="null" offset="10" sid="r10.control.n.0262" wn="4" wnkey="control%1:09:02::" text="Extensive controls lead us to believe that the RNAseH active site is most probably &quot;substrate committed&quot; in a manner similar to the &quot;template commitment&quot; of the reverse transcriptase activity." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2180-1-12.anc" start="11784" end="11795" sStart="null" offset="168" sid="r11.combination.n.0770" wn="1" wnkey="combination%1:14:00::" text="The RNAseH substrate itself (DRF+ RNA annealed to D2507-) also supported DNA synthesis in the trans assay (lane 4), as did the combination of DRF+ RNA and the non-complementary oligonucleotide D2526+ (lane 5)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2180-1-12.anc" start="20913" end="20925" sStart="null" offset="157" sid="r11.combination.n.0425" wn="1" wnkey="combination%1:14:00::" text="RNAseH assays were also carried out after removal of the endogenous nucleic acid, and multiple RNA sequences and DNA oligonucleotide combinations were employed." />
  </sentences>
</list>